Diverse roles of UBE2T in cancer (Review)

Nengqian Ma1, Zhangzhan Li2, Jingting Yan3

  • 1Department of Hepatobiliary Surgery, Affiliated Nanhua Hospital, Hengyang Medical College, University of South China, Zhuhui, Hengyang, Hunan 421002, P.R. China.

Oncology Reports
|February 24, 2023
PubMed

Insights

Aberrant ubiquitination, particularly involving ubiquitin-conjugating enzyme E2 T (UBE2T), is implicated in various cancers. Further research is needed to explore UBE2T

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Cancer pathogenesis involves genetic and epigenetic alterations.
  • Aberrant ubiquitination is a key epigenetic disruption in cancer.
  • Ubiquitin-conjugating enzyme E2 T (UBE2T) is increasingly recognized for its role.

Purpose of the Study:

  • To review the role of UBE2T in pan-cancer pathogenesis.
  • To explore UBE2T's association with chemotherapy and radiotherapy sensitivity.
  • To examine small-molecule modulators targeting ubiquitination for cancer treatment.

Main Methods:

  • Comprehensive investigation of UBE2T expression landscape and functional significance.
  • Analysis of UBE2T's correlation with treatment sensitivity.
  • Review of clinical trial data on ubiquitin enzymes and the ubiquitin-proteasome system.

Main Results:

  • Evidence indicates UBE2T plays significant roles in pan-cancer.
  • Aberrant UBE2T is linked to cancer development and progression.
  • Ubiquitin enzymes are crucial components of the ubiquitin-proteasome system.

Conclusions:

  • UBE2T is a critical factor in pan-cancer.
  • Further studies are essential to validate UBE2T as a biomarker or therapeutic target.
  • Targeting ubiquitination pathways offers potential cancer treatment strategies.

Related Concept Videos

Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
6.9K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.6K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.1K
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
5.2K